A long-surviving patient with lung pleomorphic carcinoma treated with postoperative carboplatin and paclitaxel combination chemotherapy

Shingen Nakamura, Noriaki Horiuchi, Daisuke Katsura, Kana Shichijo, Sumiko Yoshida, Eiji Harada, Takaya Matsushita, Yasushi Oshima, Yasuyuki Matsuzaki, Yasutami Tamaki, Shigeaki Kimura, Toshiaki Takeichi, Hiroshi Fujimoto, Kazuhiko Masuda, Naohito Iwasaka, Sadao Shinomiya

研究成果: ジャーナルへの寄稿学術誌査読

3 被引用数 (Scopus)

抄録

We presented the case of a 46-year-old man with no medical or family history but with a history of smoking 3 packs of cigarettes per day for the past 25 years. He was admitted to our hospital due to hemoptysis. Chest computed tomography revealed a tumor of right upper lung and interstitial pneumonia in the surrounding lung parenchyma. He was operated upon and diagnosed with stage IIB pleomorphic carcinoma of the lung with invasion of the chest wall. He underwent three courses of postoperative carboplatin (CBDCA) (area under the curve 5 on day 1, every 3 weeks and paclitaxel(PTX) (200 mg/m(2); day 1, every 3 weeks) combination chemotherapy. No recurrence was observed for a period of 760 days after the operation. According to previous reports, lung pleomorphic carcinoma is aggressive and has a poor prognosis. Further, the significance of chemotherapy in the management of this disease has not been established. Postoperative combination chemotherapy of CBDCA and PTX may result in a good prognosis for this disease.

本文言語英語
ページ(範囲)965-968
ページ数4
ジャーナルGan to kagaku ryoho. Cancer & chemotherapy
35
6
出版ステータス出版済み - 6月 2008
外部発表はい

!!!All Science Journal Classification (ASJC) codes

  • 医学一般

フィンガープリント

「A long-surviving patient with lung pleomorphic carcinoma treated with postoperative carboplatin and paclitaxel combination chemotherapy」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル